Showing results (1491-1500 of 2,161) with videos related to

Sort By:
Pageof 217
Food and Nutrition Bulletin|June 12, 2020
Preschool Child Nutritional Status in Nepal in 2016: A National Profile and 40-Year Comparative TrendK C Angela, Andrew L Thorne-Lyman, Swetha Manohar, et al.
The British Journal of Radiology|September 1, 1978
A heavy particle comparative study. Part I: depth-dose distributionsM R Raju, H I Amols, J F Dicello, et al.
Journal of Clinical Epidemiology|June 16, 2004
Hospital discharge abstract data on comorbidity improved the prediction of death among patients hospitalized with aspiration pneumoniaGeorge J Stukenborg, Douglas P Wagner, Frank E Harrell, et al.
JCO Oncology Practice|January 18, 2022
Use of Biosimilar Medications in OncologyZeina Nahleh, Gary H Lyman, Richard L Schilsky, et al.
Biochemical and Biophysical Research Communications|September 16, 1991
Molecular characterization of the interleukin-8 receptorM P Beckmann, W E Munger, C Kozlosky, et al.
The Journal of Arthroplasty|May 14, 2023
The Risk Assessment and Prediction Tool (RAPT) Score Predicts Discharge Destination, Length of Stay, and Postoperative Mobility After Total Joint ArthroplastyDrake G LeBrun, Joseph T Nguyen, Charles Fisher, et al.
Medicine and Science in Sports and Exercise|November 2, 2001
Longitudinal study of elbow and shoulder pain in youth baseball pitchersS Lyman, G S Fleisig, J W Waterbor, et al.
Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association|December 29, 2018
Development and validation of a culturally relevant Japanese KOOSStephen Lyman, Go Omori, Norimasa Nakamura, et al.
Spine|December 8, 2017
Postoperative Emergency Department Utilization and Hospital Readmission After Cervical Spine Arthrodesis: Rates, Trends, Causes, and Risk FactorsPeter B Derman, Lukas P Lampe, Ting Jung Pan, et al.
European Journal of Cancer (Oxford, England : 1990)|August 25, 2019
Three-year follow-up from a phase 3 study of SB3 (a trastuzumab biosimilar) versus reference trastuzumab in the neoadjuvant setting for human epidermal growth factor receptor 2-positive breast cancerXavier Pivot, Mark Pegram, Javier Cortes, et al.
Pageof 217